<PAGE> 1


UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

FORM 10-Q



[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934


For the quarterly period ended September 30, 2006


[  ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934


For the transition period from ____________________ to ____________________.


Commission file number:  000-50053


[f06s10q001.jpg]

AMERITYRE CORPORATION

(Exact name of small business issuer as specified in its charter)


NEVADA

87-0535207

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)



1501 INDUSTRIAL ROAD, BOULDER CITY, NEVADA

89005

(Address of principal executive offices)

(Zip Code)


(702) 294-2689

(Issuer’s telephone number)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding twelve (12) months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past ninety (90) days Yes [X] No [ ]


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Large accelerated filer [ ]

Accelerated filer [X]

Non-accelerated filer [ ]


Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [ ] No [X]


 The number of shares outstanding of Registrant’s Common Stock as of October 20, 2006: 21,031,733






PART I - FINANCIAL INFORMATION


ITEM 1.  FINANCIAL STATEMENTS


The accompanying unaudited financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission and, therefore, do not include all information and footnotes necessary for a complete presentation of our financial position, results of operations, cash flows, and stockholders' equity in conformity with generally accepted accounting principles.  In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature.


Our unaudited balance sheet at September 30, 2006 and our audited balance sheet at June 30, 2006; the related unaudited statements of operations for the three month periods ended September 30, 2006 and 2005; and the related unaudited statement of cash flows for the three month periods ended September 30, 2006 and 2005, are attached hereto.








AMERITYRE CORPORATION

Balance Sheets

 

 

 

 

 

 

 

 

Sep. 30, 2006

 

 

June 30, 2006

 

 

(unaudited)

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS

 

 

 

 

 

 

 

 

 

 

 

  Cash and cash equivalents

$

2,372,692 

 

$

3,065,675 

  Accounts receivable – net

 

186,145 

 

 

237,788 

  Inventory

 

697,055 

 

 

592,122 

  Prepaid expenses and other current assets

 

138,721 

 

 

180,742 

  Deferred stock offering expenses

 

238,271 

 

 

162,963 

  Deposit on equipment

 

26,827 

 

 

     49,373 

 

 

 

 

 

 

     Total Current Assets

 

3,659,711 

 

 

4,288,663 

 

 

 

 

 

 

PROPERTY AND EQUIPMENT

 

 

 

 

 

 

 

 

 

 

 

  Leasehold Improvements

 

157,410 

 

 

157,410 

  Molds and models

 

370,389 

 

 

375,751 

  Equipment

 

2,728,383 

 

 

2,677,687 

  Furniture and Fixtures

 

79,341 

 

 

79,341 

  Software

 

280,337 

 

 

280,337 

  Less – accumulated depreciation

 

(2,309,815)

 

 

(2,218,155)

 

 

 

 

 

 

     Total Property and Equipment

 

1,306,045 

 

 

1,352,371 

 

 

 

 

 

 

OTHER ASSETS

 

 

 

 

 

 

 

 

 

 

 

  Patents and trademarks – net

 

466,894 

 

 

463,053 

  Deposits

 

36,000 

 

 

36,000 

 

 

 

 

 

 

     Total Other Assets

 

502,894 

 

 

499,053 

 

 

 

 

 

 

TOTAL ASSETS

$

5,468,650 

 

$

6,140,087 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these unaudited financial statements.







AMERITYRE CORPORATION

Balance Sheets (Continued)

 

 

 

 

 

 

 

 

Sep. 30, 2006

 

 

June 30, 2006

 

 

(unaudited)

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

 

 

 

 

  Accounts payable

$

193,884 

 

$

246,536 

  Accrued expenses

 

116,472 

 

 

10,046 

  Deferred revenue – special projects

 

388,333 

 

 

100,000 

 

 

 

 

 

 

     Total Current Liabilities

 

698,689 

 

 

356,582 

 

 

 

 

 

 

TOTAL LIABILITIES

 

698,689 

 

 

356,582 

 

 

 

 

 

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

  Preferred stock: 5,000,000 shares authorized of $0.001 par value, -0- shares issued and outstanding

 

 

 

  Common stock: 40,000,000 shares authorized of $0.001 par value,   21,031,733 and 21,020,180 shares issued and outstanding, respectively

 

21,029 

 

 

21,018 

  Additional paid-in capital

 

47,747,063 

 

 

47,579,729 

  Deferred consulting and directors’ compensation

 

(11,667)

 

 

(29,167)

  Retained deficit

 

(42,986,464)

 

 

(41,788,075)

 

 

 

 

 

 

     Total Stockholders’ Equity

 

4,769,961 

 

 

5,783,505 

 

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

$

5,468,650 

 

$

6,140,087 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these unaudited financial statements.








AMERITYRE CORPORATION

Statements of Operations

(unaudited)

 

 

 

 

 

 

 

For the Three Months  Ended September 30,

 

 

2006

 

2005

 

 

 

 

 

NET REVENUES

 

 

 

 

  Products

$

594,236 

$

435,969 

  Licenses

 

41,667 

 

 

 

 

 

 

     Total Net Revenues

 

635,903 

 

435,969 

 

 

 

 

 

COST OF REVENUES

 

418,738 

 

354,343 

 

 

 

 

 

GROSS PROFIT

 

217,165 

 

81,626 

 

 

 

 

 

EXPENSES

 

 

 

 

 Depreciation and amortization

 

102,284 

 

89,256 

 Research and development

 

252,512 

 

236,382 

 Loss on impairment of assets

 

2,109 

 

 Selling, general and administrative

 

1,085,865 

 

985,597 

 

 

 

 

 

   Total Expenses

 

1,442,770 

 

1,311,235 

 

 

 

 

 

LOSS FROM OPERATIONS

 

(1,225,605)

 

(1,229,609)

 

 

 

 

 

OTHER INCOME

 

 

 

 

 Interest income

 

26,810 

 

17,304 

 Miscellaneous income

 

406 

 

1,052 

 

 

 

 

 

   Total Other Income

 

27,216 

 

18,356 

 

 

 

 

 

NET LOSS

$

(1,198,389)

$

(1,211,253)

 

 

 

 

 

BASIC AND DILUTED LOSS PER SHARE

$

(0.06)

$

(0.06)

 

 

 

 

 

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING

 

21,020,180 

 

19,715,806 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these unaudited financial statements.






AMERITYRE CORPORATION

Statements of Cash Flows

(unaudited)

 

 

For the Three Months Ended

 September 30,

 

 

2006

 

2005

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

Net loss

$

(1,198,389)

$

(1,211,253)

Adjustments to reconcile net loss to net cash used by operating activities:

 

 

 

 

 Depreciation & amortization expense

 

102,284 

 

89,256 

 Loss on impairment of assets

 

2,109 

 

 Stock-based compensation expense related to employee options

 

167,345 

 

144,764 

 Amortization of expense prepaid w/ common stock

 

17,500 

 

50,000 

Changes in operating assets and liabilities:

 

 

 

 

 Decrease in accounts receivable

 

51,643 

 

40,560 

 Decrease (increase) in prepaid expenses

 

42,021 

 

(32,225)

 (Increase) in other assets

 

(52,761)

 

(100,260)

 (Increase) decrease in inventory

 

(104,933)

 

31,687 

 Increase in accounts payable and accrued expenses

 

342,106 

 

132,239 

   Net Cash Used by Operating Activities

 

(631,075)

 

(855,232)

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

Cash paid for patents and trademarks

 

(9,125)

 

(19,067)

Purchase of property and equipment

 

(52,783)

 

(17,969)

   Net Cash Used by Investing Activities

 

(61,908)

 

(37,036)

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

Proceeds from the sale of common stock

 

 

1,410,000 

   Net Cash Provided by Financing Activities

 

 

1,410,000 

 

 

 

 

 

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

 

(692,983)

 

517,732 

 

 

 

 

 

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

 

3,065,675 

 

2,122,320 

 

 

 

 

 

CASH AND CASH EQUIVALENTS AT END OF PERIOD

$

2,372,692 

$

2,640,052 

 

 

 

 

 

The accompanying notes are an integral part of these unaudited financial statements.






AMERITYRE CORPORATION

Statements of Cash Flows (Continued)

(unaudited)

 

 

For the Three Months Ended

 September 30,

 

 

2006

 

2005

SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES

 

 

 

 

 

 

 

 

 

CASH PAID FOR:

 

 

 

 

Interest

$

    -

$

 -

Income taxes

$

    -

$

 -

 

 

 

 

 

NON-CASH OPERATING ACTIVITIES

 

 

 

 

Common stock issued for services rendered

$

-

$

200,000

Stock-based compensation expense related to employee options

$

167,345

$

144,764

 

 

 

 

 

NON-CASH INVESTING/ FINANCING ACTIVITIES

 

 

 

 

Common stock issued for prepaid compensation

$

-

$

200,000

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these unaudited financial statements.






AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

September 30, 2006 and June 30, 2006


NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION


The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations.  The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  Although we believe the disclosures and information presented are adequate to make the information not misleading. These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 2006 Annual Report on Form 10-K.  Operating results for the three months ended September 30, 2006 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2007.


NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Stock Based-Compensation Expense


On July 1, 2005, we adopted Statement of Financial Accounting Standards No. 123 (revised 2004), “Share-Based Payment,” (“SFAS 123(R)”) which requires the measurement and recognition of compensation expense for all share-based payments to employees and directors including employee stock options  and stock purchases related to the Company’s employee stock option and award plans based on estimated fair values. SFAS 123(R) supersedes our previous accounting under Accounting Principles Board Option No. 25, “Accounting for Stock Issued to Employees” (“APB25”) for periods beginning in fiscal 2006. In March 2005, the Securities and Exchange Commission issued Staff Accounting Bulletin No. 107 (“SAB 107”) relating to SFAS 123(R). We have applied the provisions of SAB 107 in our adoption of SFAS 123(R).


We adopted SFAS 123(R) using the modified prospective transition method, which requires the application of the accounting standard as of July 1, 2005, the first day of our fiscal year 2006. Our financial statements as of and for the three month periods ended September 30, 2006 and 2005 reflect the impact of SFAS 123(R).  Stock-based compensation expense recognized under SFAS 123(R) for the three month periods ended September 30, 2006 and 2005 was $167,345 and $144,764, respectively, related to employee stock options issued during the respective periods.


SFAS 123(R) requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our Statement of Operations. Stock-based compensation expense recognized in our Statements of Operations for the three month periods ended September 30, 2006 and 2005 assumes all awards will vest, therefore no reduction has been made for estimated forfeitures.


Basic and Fully Diluted Net Loss Per Share


Basic and Fully Diluted net loss per share is computed using the weighted-average number of common shares outstanding during the period.


 

For the Three Months Ended September 30,

 

2006

2005

Loss (numerator)

$

(1,198,389)

$

(1,211,253)

Shares (denominator)

 

21,020,180 

 

19,715,806 

Per share amount

$

$ (0.06)

$

(0.06)

 

 

 


Our outstanding stock options have been excluded from the basic and fully diluted net loss per share calculation. We excluded 4,160,000 and 4,100,000 common stock equivalents for the three month periods ended September 30, 2006 and 2005, respectively, because they are antidilutive.





AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

September 30, 2006 and June 30, 2006


NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Continued


Liquidity


Our financial statements are prepared using generally accepted accounting principles applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. We have historically incurred significant losses which have resulted in a total retained deficit of $42,986,464 at September 30, 2006.  Although for the fiscal years ended June 30, 2004, 2005 and 2006, we have losses from operations and have used cash in our operating activities in excess of our revenues, we have had little, if any, debt and have consistently had a positive net tangible book value. In connection with the preparation of our financial statements we have analyzed our cash needs for fiscal 2007. Based on this analysis, we concluded that our available cash will be sufficient to meet our current working capital, capital expenditure and other cash requirements for fiscal 2007. However to fully implement our business plan we believe we will need additional capital. We may seek to raise additional capital through the issuance of debt or equity securities. In June 2006, we filed a shelf registration statement with the Securities and Exchange Commission. The shelf registration statement, which was declared effective in July 2006, would allow us to offer common stock, preferred stock, warrants, senior debt securities and subordinated debt securities or any combination of any of these securities in one or more offerings at an aggregate initial offering price not to exceed $120,000,000. Our ability to obtain financing through the offer and sale of our securities is subject to market conditions and other factors beyond our control. We cannot assure you that we will be able to obtain financing on favorable terms or at all.



NOTE 3 - STOCK OPTIONS


General Option Information


During the three month period ended September 30, 2006, we did not grant any options. During the three month period ended September 30, 2005, we granted options to acquire an aggregate of 625,000 shares of our common stock to certain employees in connection with their employment (the “Employment Options”). The Employment Options granted during the three month period ended September 30, 2005 vest annually over a period of one to three years based on the employee’s continued employment. The exercise price for the Employment Options granted during the period is $6.60 per share.  We use the Black-Scholes model to value stock options. The Black-Scholes model requires the use of employee exercise behavior data and the use of a number of assumptions, including volatility of our stock price, the weighted average risk-free interest rate, and the weighted average expected life of the options. Because we do not pay dividends, the dividend rate variable in the Black-Scholes model is zero. We estimated the fair value of the stock options at the grant date based on the following weighted average assumptions:


 

For the three month period ended

September 30, 2006

For the three month period ended

September 30, 2005

Risk free interest rate

N/A

4.13%

Expected life

N/A

3 years

Expected volatility

N/A

57.693%

Dividend yield

N/A

0.00%






AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

September 30, 2006 and June 30, 2006


NOTE 3 - STOCK OPTIONS (Continued)


A summary of the status of our outstanding stock options as of September 30, 2006 and June 30, 2006 and changes during the periods then ended is presented below:                                                       


 

September 30, 2006

June 30, 2006

 


Shares

Weighted Average Exercise Price


Shares

Weighted Average Exercise Price

Outstanding beginning of period

4,190,000 

$6.69 

3,945,000 

$6.31 

Granted

 -

-

775,000 

$6.36 

Expired/Cancelled

-

-

(60,000)

$(6.70)

Exercised

  (30,000)

$(3.80)

  (470,000)

$(3.00)

Outstanding end of period

 4,160,000 

$6.71

 4,190,000 

$6.69 

Exercisable

  3,660,000 

$6.76

    415,000 

$5.06 

 

 

 

 

 


The following table summarizes the range of outstanding and exercisable options as of September 30, 2006:


 

Outstanding

Exercisable


Range of

Exercise Prices


Number Outstanding at

Sep. 30, 2006

Weighted

Average

Remaining

Contractual Life


Weighted

Average

Exercise Price


Number

Exercisable at

Sep. 30, 2006


Weighted

Average

Exercise Price

$4.00

200,000

0.69

$4.00

200,000

$4.00

5.36

150,000

5.75

$5.36

50,000

$5.36

6.40

185,000

2.34

$6.40

185,000

$6.40

6.60

625,000

5.71

$6.60

225,000

$6.60

7.00

3,000,000

2.96

$7.00

3,000,000

$7.00

$4.00-$7.00

4,160,000

3.34

$6.71

 3,660,000

$6.76

 

 

 

 

 

 


As of September 30, 2006, the unrecognized stock-based compensation related to stock options was approximately $1,199,788. This cost is expected to be expensed over a weighted average period of 2.34 years.


NOTE 4 - STOCK ISSUANCES


On September 30, 2006, we issued 11,553 shares of our common stock to an officer pursuant to the cashless exercise of 30,000 outstanding stock options.



NOTE 5 - INVENTORY


Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or market.  The inventory consists of chemicals, finished goods produced in our plant and products purchased for resale.



 

Sep 30, 2006

(Unaudited)

June 30, 2006

Raw Materials

$

$161,117

$

$139,658

Work in Progress

$

-

$

-

Finished Goods

$

535,938

$

452,464

Total Inventory

$

697,055

$

592,122

 

 

 






AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

September 30, 2006 and June 30, 2006



NOTE 6 – License Fees


The table below sets forth the contractual aggregate license revenue from manufacturing licenses granted by us to licensees during the three month period ended September 30, 2006.


 

 

 

 

Fiscal Year 2007

 

Fiscal Years

 

 

Total

 

Sept. 30, 2006

 

Dec. 31, 2006

 

Mar. 31, 2007

 

Jun. 30, 2006

 

2008-2016

License Fees (1) (2)

$

1,400,000

$

41,667

$

75,000

$

75,000

$

75,000

$

1,133,333


(1) The License Agreement with Flatfree-Korea provides for an annual minimum license payments of $100,000 per year over an initial term of 10 years.


(2) The License Agreement with Qingdao Qizhou Rubber Co., Ltd., provides for an aggregate $400,000 license fee payable to us in quarterly installments over two (2)  years beginning September 1, 2006.



NOTE 7 – SUBSEQUENT EVENT


In October 2006, we gave our landlord notice that we intend to exercise our option to purchase the building and related real property located at 1501 Industrial Road for the purchase price of $2,600,000, pursuant to an option to purchase the property contained in our lease agreement. We provided an earnest money deposit of $25,000, which will be applied towards the purchase price. It is anticipated that the closing of the purchase will take place after January 1, 2007, subject to us obtaining adequate financing for the purchase. We will continue to pay the monthly lease amount of $18,000 until the closing of the purchase. The property consists of a 49,200 square foot building, which includes approximately 5,500 square feet of office space, situated on approximately 4.15 acres.






ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


This discussion and analysis contains statements of a forward-looking nature relating to future events or our future financial performance or financial condition.  Such statements are only predictions and the actual events or results may differ materially from the results discussed in or implied by the forward-looking statements. The historical results set forth in this discussion and analysis are not necessarily indicative of trends with respect to any actual or projected future financial performance.  This discussion and analysis should be read in conjunction with the financial statements and the related notes thereto included elsewhere in this report.


Overview

We were incorporated as a Nevada corporation on January 30, 1995 under the name American Tire Corporation and changed our name to Amerityre Corporation in December 1999.  Since our inception in 1995, we have been engaged in the research and development of technologies related to the formulation of polyurethane compounds and the manufacturing process for producing tires constructed of polyurethane.  We believe that we have developed unique polyurethane formulations that allow for the creation of tire products with superior performance characteristics, including abrasion resistance and load-bearing capabilities, compared to those of conventional rubber tires.  In addition, we believe that the manufacturing processes we have developed are more efficient than traditional tire manufacturing processes, in part because our polyurethane compounds do not require the processing steps, extreme heat, and high pressure that are necessary to cure rubber.  Using our polyurethane technologies, we believe tires can be produced that are cost-competitive, and more durable and more fuel efficient than existing rubber tires.

Within the overall tire market, we have chosen to focus our immediate attention and resources on the specialty tire segment.  We believe industries that rely upon specialty tires, such as mining, materials handling, construction, agriculture and forestry, are well suited to benefit from our polyurethane technologies due to their severe operating conditions, the high cost of tire failure and current tire shortages.

We intend to pursue a commercialization strategy that includes expanding our existing manufacturing capacity as well as transferring our technology to strategic partners consisting of industry leading tire manufacturers and users of specialty tires.  We currently have the capacity to produce up to 2,000,000 closed-cell foam or solid, Elastothane TM (non-pneumatic) polyurethane tires per year at our Boulder City, Nevada facility.  Subject to our obtaining adequate financing, we plan to construct and operate, either by ourselves or with a strategic partner, a manufacturing facility that would give us the capacity to retread approximately 7,200 OTR tires per year using ElastothaneTM.  We also intend to commercialize our ElastothaneTM tire products, including medium commercial truck retreads, Arcus® pneumatic and non-pneumatic tires, by transferring our technology to our strategic partners through licensing agreements, co-development projects and the sale of equipment and our proprietary chemical formulations.  


We intend to commercialize our polyurethane technologies through licensing agreements, co-development projects, and the sale of equipment, chemical formulations and tire products to strategic partners consisting of industry leading tire manufacturers and users of specialty tires.  We expect these strategic relationships to result in revenue opportunities for Amerityre as well as further development of polyurethane technologies.  We have already begun to establish important relationships:


·

In October 2005, we entered into a development agreement with Genmar Holdings, Inc., a leading recreational boat manufacturer, to design and develop a polyurethane elastomer run-flat tire for boat trailers.  When we entered into this agreement, we estimated the project would require approximately six months before we would have prototype tires available for testing.  Due to unforeseen delays associated with the receipt and set-up of tooling and manufacturing equipment, our estimate for completing this development has been extended to December 31, 2006.


·

In July 2006, we entered into an agreement with a South Korean company to manufacture and distribute our polyurethane closed-cell foam tire products in Asia.


·

In August 2006, we entered into a memorandum of understanding with a manufacturer of specialty tires to develop, produce and test solid tires, semi-solid tires, off-the-road (OTR) tires and medium radial truck





retreads made with our polyurethane elastomer compound.


·

In September 2006, we entered into a manufacturing license agreement with a Chinese company to manufacture retreads using our polyurethane elastomer compound for large size OTR tires used in mining operations.


·

In September 2006, we entered into an agreement with Phelps Dodge Mining Company to evaluate polyurethane elastomer retreads for large size OTR tires. We will develop and produce several polyurethane elastomer retreads for OTR tires and Phelps Dodge will provide the OTR tire casings.


We believe that we have identified new, innovative applications of polyurethane formulations and that our proprietary technologies allow for the development of products that otherwise could not be produced using polyurethane.  We intend to expand our intellectual property portfolio through our own research and development as well as co-development efforts with industry leaders.  During the current quarter, the United States Patent and Trademark Office issued a patent to us relating to the methods we use to put reinforcement materials (beads, belts and plies) in a polyurethane tire.  We have nine additional patent applications pending relating to our tire technology. By expanding our intellectual property, we believe that we will strengthen our competitive position and continue to be an innovator in the development of polyurethane technologies.


As a company focused on the advanced chemistry and potential innovative applications of polyurethane, we believe there is a significant opportunity to apply our materials to several industries.  The high price of rubber, combined with its inherent limitations, demonstrates the need for and potential benefits of alternative materials.  We believe that significant product performance improvements can be realized by substitution of our unique polyurethane compounds for both rubber and inferior polyurethane compounds.  While our current focus is on our existing products, there are numerous markets that can benefit from products made with either our polyurethane foam or elastomer compounds as a result of their unique product requirements, such as:


·

Carpet backing

·

Marine floatation

·

Building materials

·

Insulation

·

Protective coatings

·

Tire fill

·

Encapsulated glass products (i.e., sunroofs, fixed window panels and rear sliding windows)

·

Hoses and vehicle tracks

·

Conveyor belts and equipment liners



Factors Affecting Results of Operations

While the sale of polyurethane foam tires to original equipment manufacturers, distributors and retail stores accounts for almost all of our revenue at this time, ElastothaneTM and the technology to produce tires using this proprietary formulation are significant to our potential future growth.  Our business model provides for a diversified revenue stream.  We intend to generate revenue through license agreements relating to the use of our patented manufacturing methods and systems; the sale of specialty equipment; the sale of proprietary chemical systems; the sale of a select number of finished tire products; and contract research and development services.  

Historically, our expenses have exceeded our revenues. In each of these periods, our expenses consisted primarily of the following:

·

Cost of revenues, which consists primarily of raw materials, components and production of our products, including applied labor costs and benefits expenses, maintenance, facilities and other operating costs associated with the production of our products;

·

Selling, general and administrative expenses, which consist primarily of salaries, commissions and related benefits paid to our employees and related selling and administrative costs including professional fees; and

·

Research and development expenses, which consist primarily of equipment and materials used in the development of our technologies;





·

Consulting expenses, which consist primarily of amounts paid to third-parties for outside services and amounts paid to Centurion Holdings, LLC, for advisory services related to capital raising and operational strategies;

·

Depreciation and amortization expenses which result from the depreciation of our property and equipment, including amortization of our intangible assets; and

·

Amortization of deferred compensation that results from the expense related to certain stock options to our employees.

Critical Accounting Policies


Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses.  On an ongoing basis, we evaluate our estimates, including those related to uncollectible receivables, inventory valuation, deferred compensation and contingencies.  We base our estimates on historical performance and on various other assumptions that we believe to be reasonable under the circumstances.  These estimates allow us to make judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.


We believe the following accounting policies are our critical accounting policies because they are important to the portrayal of our financial condition and results of operations and they require critical management judgments and estimates about matters that may be uncertain.  If actual results or events differ materially from those contemplated by us in making these estimates, our reported financial condition and results of operations for future periods could be materially affected.


Revenue Recognition


Revenue is recognized when the sales amount is determined, shipment of goods to the customer has occurred and collection is reasonably assured. Generally, we ship all of our products FOB origination.


Valuation of Intangible Assets and Goodwill


At September 30, 2006, we had capitalized patent and trademark costs, net of accumulated amortization expenses, totaling $466,894.  The patents which have been granted are being amortized over a period of 20 years.  Patents which are pending or are being developed are not amortized until a patent has been issued.  Amortization expense for the fiscal years ended June 30, 2006, 2005 and 2004 was $25,514, $30,847 and $1,309, respectively.  We evaluate the recoverability of intangibles and review the amortization period on a continual basis utilizing the guidance of Statement of Financial Accounting Standards “SFAS” No. 142, "Goodwill and Other Intangible Assets."  We test our patents and trademarks for impairment at least annually and whenever events or changes in circumstances indicated that the carrying value may not be recoverable.  We consider the following indicators, among others, when determining whether or not our patents are impaired:


·

any changes in the market relating to the patents that would decrease the life of the asset;


·

any adverse change in the extent or manner in which the patents are being used;


·

any significant adverse change in legal factors relating to the use of the patents;


·

current-period operating or cash flow loss combined with our history of operating or cash flow losses;


·

future cash flow values based on the expectation of commercialization through licensing; and


·

current expectations that, more likely than not, the patents will be sold or otherwise disposed of significantly before the end of its previously estimated useful life.







Inventory

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or market.  The inventory consists of chemicals, finished goods produced in our plant and products purchased for resale.

Stock-Based Compensation

Equity securities issued for services rendered have been accounted for at the fair market value of the securities on the date of authorization.

On July 1, 2005, we adopted SFAS No. 123 (revised 2004), “Share-Based Payment,” (“SFAS 123(R)”) which requires the measurement and recognition of compensation expense based on estimated fair values for all share-based payments to employees and Directors, including employee stock options and stock purchases related to our employee stock option and award plans.  SFAS 123(R) supersedes our previous accounting under Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees” (“APB 25”) for periods beginning in the fiscal year ended June 30, 2006.  In March 2005, the SEC issued Staff Accounting Bulletin No. 107 (“SAB 107”) relating to SFAS 123(R).  We have applied the provisions of SAB 107 in our adoption of SFAS 123(R).

We adopted SFAS 123(R) using the modified prospective transition method, which requires the application of the accounting standard as of July 1, 2005, the first day of our fiscal year ended June 30, 2006.  Our financial statements as of and for the three month periods ended September 30, 2006 and 2005 reflect the impact of SFAS 123(R).  Stock based compensation expense recognized under SFAS 123(R) for the three month periods ended September 30, 2006 and 2005 was $167,345 and $144,764, respectively, related to employee stock options issued during the respective periods.

SFAS 123(R) requires companies to estimate the fair value of share-based payment awards on the date of grant using an option pricing model.  The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our Statement of Operations. Under SFAS 123(R), stock-based compensation expense recognized during the period is based on the value of the portion of share-based payment awards that is ultimately expected to vest during the period.  Stock-based compensation expense recognized in our Statement of Operations for the three month periods ended September 30, 2006 and 2005 assumes all awards will vest, therefore, no reduction has been made for estimated forfeitures.

Seasonality

A substantial majority of our sales are to customers within the United States. We experience some seasonality in the sale of our closed-cell polyurethane foam tires for bicycles and lawn and garden products because sales of these products generally decline during the winter months in the United States.  Sales of our closed-cell polyurethane form tire products generally peak during the spring and summer months, typically resulting in greater sales volumes during the third and fourth quarters of the fiscal year.

Results of Operations

Our management reviews and analyzes several key performance indicators in order to manage our business and assess the quality and potential variability of our revenues and cash flows. These key performance indicators include:

·

Net revenues, which consists of sales revenues and license fees;

·

Sales revenue, net of returns and trade discounts, which is an indicator of our overall business growth and the success of our sales and marketing efforts;

·

Gross profit, which is an indicator of both competitive pricing pressures and the cost of revenues of our products;

·

Growth in our customer base, which is an indicator of the success of our sales efforts; and

·

Distribution of revenue across our products offered.





The following summary table presents a comparison of our results of operations for the three month periods ended September 30, 2006 and 2005 with respect to certain key financial measures.  The comparisons illustrated in the table are discussed in greater detail below.

 

 

Three Month Period Ended September 30,

 

Percent Change

 

 

 

 

2006

 

2005

 

2006

vs.

2005

 

 

 

Net revenues (1)

 

 

$

635,903

$

435,969

 

46%

Cost of revenues

 

 

$

418,738

$

354,343

 

18%

Gross profit

 

 

$

217,165

$

81,626

 

167%

Selling, general, and administrative expenses (2)

 

 

$

 1,085,865

$

985,597

 

10%

Research and development expenses

 

 

$

252,512 

$

236,382

 

7%

Depreciation and amortization expenses

 

 

$

102,284 

$

89,256

 

15%

Loss on sales and impairment of assets

 

 

$

2,109 

$

 

100%

Other Income

 

 

$

27,216 

$

18,356 

 

48%

Net loss

 

 

$

(1,198,389)

$

(1,211,253)

 

(1)%


(1) Includes $41,667 of license revenue in the three months ended September 30, 2006 with no associated cost of revenues for the period.

(2) Includes deferred compensation for employee stock options of $167,345 and $144,764 in the three month periods ended September 30, 2006 and 2005, respectively.


Three Month Period Ended September 30, 2006 Compared to September 30, 2005

Net revenues.   Sales of our closed-cell polyurethane foam products accounted for all but $41,667 of our net revenues during the three month period ended September 30, 2006. The $41,667 was derived from fees received from third-party licensees for use of our technology. For the three month period ended September 30, 2006 we had $635,903 of net revenues compared to $435,969 for the same period for 2005.  Net revenues for the three month period ended September 30, 2006 increased by $199,934, or 46%, as compared with 2005 due to a combination of licensee fees, an increase in the number of product units sold and an increase in product pricing effected during the period. During the three month period ended September 30, 2006 we had $8,718 and $4,429 of returns of our products and trade discounts, respectively, compared to $2,488 and $2,926, respectively, for the same period in 2005.

Cost of revenues.  For the three month period ended September 30, 2006 our total cost of revenues was $418,738, or 66% of net revenues, compared to $354,343, or 81% of net revenues for the same period in 2005.  Excluding $41,667 of licensee revenue with no associated cost of revenues, our cost of revenues as a percentage of net revenues decreased  11% to 70% of net revenues for the three months ended September 30, 2006, as compared with the same period in 2005. The reduction in our cost of revenues was a result of increased pricing for our products and reduced pricing obtained on chemical raw materials and wheel components.  We believe that our cost of revenues can improve as our increased sales efforts generate additional product orders to take further advantage of manufacturing efficiencies.  During the balance of the fiscal year ending June 30, 2007, we believe that the foregoing measures will continue to allow us to recapture some of the decrease in gross margin we experienced in the fiscal





year ended June 30, 2006. However, we believe that it is too early to predict the extent to which our cost of revenues may be reduced or how long this reduction will continue.  We believe we currently have sufficient foam product manufacturing equipment and employees to accomplish a substantial increase in production without incurring a proportionately equivalent increase in labor costs.

Gross Profit.  For the three month period ended September 30, 2006 we had $217,165 of gross profit compared to $81,626 for the same period in 2005.  Gross profit for the three month period ended September 30, 2006 increased by $135,539, or 167%, over same period in 2005 due primarily to the increase in net revenues and the additional revenue related to third-party license fees.  Our gross profit margin increased to 34% in 2006 from 19% for the same period in 2005.  The increase in our gross profit for the three month period ended September 30, 2006 as compared to the three month period ended September 30, 2005 was the result of 7% of net revenues derived from third-party license fees, combined with an increase in product pricing.  During the balance of the fiscal year ending June 30, 2007, we believe that the foregoing factors will allow us to maintain or improve our gross margin consistent with the three months ended September 30, 2006.

Selling, General, and Administrative Expenses.  For the three month period ended September 30, 2006 we had $1,085,865 of SG&A expenses, including the amortization of deferred compensation, compared to $985,597 for the same period in 2005.  As we increased our commercialization efforts our SG&A for the three month period ended September 30, 2006 increased by $100,268, or 10%, as compared with the same period in 2005, due primarily to increased expenses in the following areas: approximately $79,000 in additional expense for the hiring of additional management personnel; and approximately $21,000 in deferred compensation, which is primarily related to the grant of options to our employees for the purchase of restricted stock. We amortized $167,345 of deferred compensation for the three month period ended September 30, 2006 compared to $144,764 for same period in 2005.  We anticipate that SG&A for the balance of the 2007 fiscal year will be consistent with the three months ended September 30, 2006.

Research and Development Expenses.  For the three month period ended September 30, 2006 we had $252,512 of research and development expenses compared to $236,382 for the same period in 2005.  Our research and development expenses for the three month period ended September 30, 2006, increased by $16,130, or 7%, as compared with the same period in 2005 due primarily to an increase in outside testing services and the hiring of additional research and development technicians during the period.  We expect research and development expenses to increase approximately 25% during the balance of the fiscal year ending June 30, 2007 as we identify and pursue research and development projects of additional applications for our polyurethane technology outside the tire industry.

Consulting Expenses.  For the three month period ended September 30, 2006, we had $11,111 in outside consulting expenses.  We had no outside consulting expenses for the same period in 2005.  During the balance of the fiscal year ending June 30, 2007 we expect consulting expenses to increase significantly, after taking into account our agreement to pay Centurion Holdings, LLC, or Centurion, $41,667 per month beginning October 2006 through September 2008 for assisting us with our marketing and capital raising efforts and on various other operational strategies.  

Depreciation and Amortization Expenses.  For the three month period ended September 30, 2006 we had $102,284 of depreciation and amortization expenses compared to $89,256 for the same period in 2005.  Our depreciation and amortization expenses for the three month period ended September 30, 2006 increased by $13,028, or 15%, compared to the same period in 2005, due to the addition of newly acquired assets during the period.

Net Loss.  For the three month period ended September 30, 2006 we had a net loss of $1,198,389 compared to a net loss of $1,211,253 for the same period in 2005.  Our net loss for the three month period ended September 30, 2006 decreased by $12,864 as compared with the same period in 2005, due primarily to the increase in the gross profit margin for the three month period ended September 30, 2006.

Liquidity and Capital Resources

Our principal sources of liquidity consist of cash and cash equivalents and payments received from our customers.  We have no long-term liabilities, and we do not have any significant credit arrangements.  Historically, our expenses have exceeded our revenues, resulting in operating losses.  From time to time, we have obtained additional liquidity to fund our operations through the sale of shares of our common stock.  In assessing our





liquidity, our management reviews and analyzes our current cash balances on-hand, short-term investments, accounts receivable, accounts payable, capital expenditure commitments and other obligations.

Cash Flows

The following table sets forth our consolidated cash flows for the three month periods ended September 30, 2006 and 2005.

 

 

Three Months Ended September 30,

 

 

 

2006

 

 

 

2005

 

 

 

 

 

Net cash used by operating activities

 

$

(631,075

)

 

 

 

$

(855,232

)

Net cash used in investing activities

 

(61,908

)

 

 

(37,036

)

Net cash provided by financing activities

 

-

 

 

 

1,410,000

 

Net (decrease) increase in cash and cash equivalents during period

 

$

(692,983

)

 

 

 

$

517,732

 

 

 

 

 

 

 

 

 

 

 

 


Net Cash Used By Operating Activities.  Our primary sources of operating cash during the three month period ended September 30, 2006 was receipts from our customers.  Our primary uses of operating cash are payments made to our vendors and employees. Net cash used by operating activities was $631,075 for the three months ended September 30, 2006 compared to $855,232 for the same period in 2005.  The decrease in cash used in operating activities is due to increases in inventory, accounts payable and accrued expenses for the three months ended September 30, 2006 compared to the same period in 2005.  Non-cash items include depreciation and amortization and stock based compensation.  Our net loss was $1,198,389 for the three months ended September 30, 2006 compared to a net loss of $1,211,253 for the same period in 2005.  Net loss for the three month period ended September 30, 2006 included non-cash expenses of $167,345 for stock-based compensation related to employee stock options and $102,284 for amortization and depreciation expenses.  


Net Cash Used In Investing Activities.  Net cash used by investing activities was $61,908 for the three month period ended September 30, 2006 and $37,036 for the same period in 2005.  Our primary uses of investing cash for the three month period ended September 30, 2006 were $9,125 deposits on patents and trademarks and $52,783 for property and equipment.  Our primary use of investing cash for the three month period ended September 30, 2005 was $19,067 for patents and trademarks and $17,969 for property and equipment.

 

Net Cash Provided by Financing Activities.  During the three months ended September 30, 2006, we did not engage in any financing activities. During the three month period ended September 30, 2005, financing activities provided net cash of $1,410,000, received in connection with the issuance of common stock on the exercise of outstanding options for cash.


Cash Position and Outstanding Indebtedness


Our total indebtedness at September 30, 2006 was $698,689 and our total cash and cash equivalents were $2,372,692, none of which is restricted.  Our total indebtedness at September 30, 2006 includes $193,884 in accounts payable, $116,472 in accrued expenses, primarily consisting of legal and consulting expenses, and $388,333 in deferred revenue, primarily consisting of pre-paid license and development fees. We have no long-term liabilities.





Contractual Obligations and Commitments

The following table summarizes our contractual cash obligations and other commercial commitments at September 30, 2006.

 

 

Payments due by period

 

 

 

Total

 

Less than
1 year

 

1 to 3 years

 

3 to 5 years

 

After
5 years

 

 

 

(in thousands)

 

Facility lease (1)

 

$

216

 

 

$

216

 

 

$

 

 

$

 

$

 

Other long-term liabilities (2)

 

1,000

 

 

500

 

 

500

 

 

 

Total contractual cash obligations

 

$

1,216

 

 

$

716

 

 

$

500

 

$

 

$

 


(1)  In October 2002, we leased our executive and manufacturing facilities located at 1501 Industrial Road, Boulder City, Nevada.  The property consists of a 49,200 square foot building, which includes approximately 5,500 square feet of office space, situated on approximately 4.15 acres.  The term of the lease is five years expiring October 14, 2007, subject to our right to purchase the property.  The base rent is $16,000 per month for the first year, with annual increases of $500 per month during the term of the lease.  In October 2006, we gave our landlord notice that we intend to exercise our option to purchase the property for the purchase price of $2,600,000. We provided an earnest money deposit of $25,000.00, which will be applied towards the purchase price. It is anticipated that the closing of the purchase will take place after January 1, 2007, subject to us obtaining adequate financing for the purchase. We will continue to pay the monthly lease amount of $18,000 until the closing of the purchase.


(2)  In September 2004, we entered into an agreement with Centurion whereby Centurion assists us with our marketing and capital raising efforts and on various other operational strategies.  In exchange for such services we pay to Centurion $41,667 per month or $500,000 per year, beginning September 2006 and continuing through September 2008.


Future Capital Requirements


We believe that our cash on hand will be adequate to meet our current working capital, capital expenditure, and other cash requirements, however, to fully implement our business plan, we believe we will need additional capital  We may seek to raise additional capital through the issuance of debt or equity securities. In June 2006, we filed a shelf registration statement with the Securities and Exchange Commission. The shelf registration statement, which was declared effective in July 2006, would allow us to offer common stock, preferred stock, warrants, senior debt securities and subordinated debt securities or any combination of any of these securities in one or more offerings at an aggregate initial offering price not to exceed $120,000,000. Our ability to obtain financing through the offer and sale of our securities is subject to market conditions and other factors beyond our control. We cannot assure you that we will be able to obtain financing on favorable terms or at all.


 Although we believe that we will successfully implement our business plan, management cannot give any assurances that it will be able to do so or that we will ever operate profitably.  Our business plan assumes, among other things, that our selling, general and administrative expenses will continue at a rate similar to the rate we experienced for the three month period ended September 30, 2006, that we will not experience a material decline in our product pricing, and that we will not experience a material increase in our customer bad debt.  We are now obligated to pay Centurion $41,667 per month or $500,000 per year for two years for assisting us with our marketing and capital raising efforts and on various other operational strategies.  Finally, subject to obtaining adequate financing, we have elected to purchase our manufacturing facility, which we currently lease and we also may decide to build an OTR retread facility.

Off-Balance Sheet Arrangements

We do not currently have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts.






Recent Accounting Pronouncements

In September 2006, the Securities and Exchange Commission (SEC) issued Staff Accounting Bulletin (“SAB”) No. 108 which provides interpretive guidance on how the effects of the carryover or reversal of prior year misstatements should be considered in quantifying a current year misstatement. SAB No. 108 is effective for us as of January 1, 2007. We are currently evaluating the impact of SAB No. 108 on our financial statements


Statement of Financial Accounting Standards No. 157, Fair Value Measurements  (“SFAS 157”), defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles (GAAP), and expands disclosures about fair value measurements. The Company will adopt the provisions of SFAS 157 effective January 1, 2008. We do not expect SFAS 157 to have a material impact on our results of operations, financial position, or cash flows.

Statement of Financial Accounting Standards No. 158, Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans—an amendment of FASB Statements No. 87, 88, 106, and 132(R) (“SFAS 158”), improves financial reporting by requiring an employer to recognize the overfunded or underfunded status of a defined benefit postretirement plan as an asset or liability in its statement of financial position and to recognize changes in that funded status in the year in which the changes occur through comprehensive income.  SFAS 158 will not have an impact on our results of operations, financial position, or cash flow.



ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK


We are exposed to changes in prevailing market interest rates affecting the return on our investments but do not consider this interest rate market risk exposure to be material to our financial condition or results of operations.  We invest primarily in United States Treasury instruments with short-term (less than one year) maturities.  The carrying amount of these investments approximates fair value due to the short-term maturities.  Under our current policies, we do not use derivative financial instruments, derivative commodity instruments or other financial instruments to manage our exposure to changes in interest rates or commodity prices.


ITEM 4. CONTROLS AND PROCEDURES


We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.


As required by SEC Rule 13a-15(b), an evaluation was performed under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based upon that evaluation, our management, including our principal executive officer and our principal financial officer, concluded that the design and operation of these disclosure controls and procedures were effective at the reasonable assurance level.


There has been no change in our internal controls over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.







PART II - OTHER INFORMATION


ITEM 1.  LEGAL PROCEEDINGS


We are involved in legal proceedings in the normal course of our business that we do not expect to have a material adverse effect on our business, financial condition or results of operations.  The significant proceedings in which we are involved are discussed below.

In November 2005, Continental Automotive Licensing Corp. filed a petition for Cancellation #92045199 in the United States Patent and Trademark Office against Richard A. Steinke, our Chairman and Chief Executive Officer, concerning the registration of Amerityre®, Registration No. 2,401,989.  Petitioner alleges that it has been damaged by the continued existence of the Amerityre® trademark and has asked the Trademark Office to cancel the registration.  Automotive Licensing Corp. bases its petition on its use and registration of various marks incorporating “AMERI” for tires.  Our registration and the Amerityre® trademark was issued November 7, 2000 by the Trademark Office to Mr. Steinke and assigned by him to us in June 2001.  We believe that we have strong defenses to the petition and we plan to vigorously defend our use and registration of the trademark.

ITEM 1A. RISK FACTORS

 

For information regarding risk factors, see “Part I. Item 1A. Risk Factors,” in our Annual Report on Form 10-K for the year ended June 30, 2006.


ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS


None.


ITEM 3.  DEFAULTS UPON SENIOR SECURITIES


None.


ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS


None.


ITEM 5.  OTHER INFORMATION


Our Annual Meeting of Stockholders will be held in the Sunset Room at the Sunset Station Hotel and Casino, 1301 West Sunset Road, Henderson, Nevada 89014, on Friday, December 1, 2006, at 10:00 am, Pacific Time, to:


1. Elect six directors to serve until the 2007 Annual Meeting of Stockholders;

2. Ratify the selection of HJ & Associates, LLC as the Company’s independent auditor for the Company’s fiscal year ending June 30, 2007;

3. Transact such other business as may properly come before the Annual Meeting or any adjournment thereof.


The foregoing matters are described in more detail in our Proxy Statement mailed to all stockholders and filed with the Commission on or about October 20, 2006.






ITEM 6.  EXHIBITS


Exhibit 31.01 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.


Exhibit 31.02 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.


Exhibit 32.01 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.


Exhibit 32.02 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.


SIGNATURES


In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Dated: October 31, 2006


AMERITYRE CORPORATION


/S/RICHARD A. STEINKE

Richard A. Steinke

Chief Executive Officer


/S/ANDERS A. SUAREZ

Anders A. Suarez

Chief Financial Officer and

Principal Accounting Officer